BATS BZX Real-Time Price
As of 11:32am ET
| +0.21 / +4.93%|
The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 9.50, with a high estimate of 23.00 and a low estimate of 5.00. The median estimate represents a +112.53% increase from the last price of 4.47.
The current consensus among 6 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.